Your DNA Is Unique, So Why Isn’t Your Prescription?
Mantara’s PGx test enables your healthcare professional to choose the best medication for your DNA, improving outcomes and minimising effects.
Award Winning
•
Featured in The Lancet Journal
•
Clinically Proven
•
Secure, Encrypted Data Handling
•
Evidence Based Insights
•
Award Winning • Featured in The Lancet Journal • Clinically Proven • Secure, Encrypted Data Handling • Evidence Based Insights •
Choose the correct Medication at the right dose with Mantara PGx test
Our DNA influences how our bodies react to different medicines. Not every medication works the same for everyone: some only help certain people, some need dose adjustments, and others can cause unwanted side effects.
Pharmacogenomic (PGx) testing uses a person’s DNA to guide medication choices. It helps healthcare professionals select the most suitable drug and the right dose, increasing the chances that the treatment will work well while reducing the risk of adverse reactions.
The Importance of Personalised Medicine
At Mantara, we’re driven by a simple belief: healthcare works best when it’s tailored to the individual. Pharmacogenomic (PGx) testing gives us the power to move beyond guesswork and choose treatments based on a person’s unique DNA. This approach can help patients feel better, faster.
By using a person’s DNA to guide treatment decisions, we can replace uncertainty with precision and transform the way care is delivered.
Personalised medicine isn’t a distant vision. With PGx testing, it’s within reach — and Mantara is committed to making it a reality for everyone.
The Challenge
Ineffective Prescriptions
Up to 90% of prescription medications are effective in only 30–50% of patients, leading to suboptimal treatment outcomes.
Adverse Drug Reactions
Adverse drug reactions account for 1 in 20 occupied hospital beds in the UK and cost the NHS an estimated £2.2 billion each year.
The Solution
Pharmacogenomic (PGx) Testing
PGx testing has been shown to reduce clinically significant adverse drug reactions by approximately 30%, improving patient safety and treatment precision.
NICE Recommends Genetic Testing
for Clopidogrel
Around 30% of people have a genetic variant that makes Clopidogrel less effective, which can increase the risk of another stroke. Mantara’s PGx test checks for CYP2C19 variants in line with NICE’s 2024 guidance, helping clinicians choose the safest and most effective treatment for you.
Now Offering: Rapid Clopidogrel
Genetic Test
Mantara now provides a fast CYP2C19 genetic test specifically for people taking Clopidogrel. This quick, focused test gives results within days and helps identify whether the medication is likely to work well for you. It’s a simple way to support safer, more effective protection against stroke and heart attack.
Knowledge is the Best Medicine ™
A personalised approach to treatment can make a real difference, especially if you’ve experienced medicines that haven’t worked well or have caused unwanted side effects. Understanding how your body processes medication is a powerful step toward safer, more effective care.
Our PGx tests can help guide treatment decisions across a wide range of conditions, including high cholesterol, anxiety and depression, acid reflux, and stroke prevention.
Why Mantara?
Mantara Health was founded by doctors who believe every patient deserves truly personalised care. Our mission is to provide high‑quality, evidence‑based DNA testing that helps healthcare professionals make safer, more informed prescribing decisions.
-
COMPREHENSIVE RESULTS
Our PGx panel analyses 12 key genes, offering a far more complete picture than tests that only look at one or two. This means clearer insights and more confident treatment decisions.
-
DATA PROTECTION
Your genetic information is handled with the highest level of confidentiality. We protect your data with strict security measures and will never share your results with industry partners.
-
78 MEDICINES COVERED
Our test focuses only on medications supported by the strongest, clinically actionable PGx evidence. This ensures that every result you receive is meaningful and relevant to your care.
-
CE & UKCA MARKED
Our PGx test is approved by the MHRA and carries both CE and UKCA marks, reflecting rigorous quality standards and reliable clinical performance.
As Seen In
Awards
Industry Partners
-
![]()
“It’s a no brainer to me and the change I made to my statin medication improved my quality of life significantly.”
- Mr C, Kent -
![]()
“This really is AI in medicine and I hope the NHS will be offering it in the future.”
- Mrs P, Kent -
![]()
"I was taking statins to manage my cholesterol but started experiencing muscle pain, fatigue, and general discomfort. After taking the Mantara PGx test, I found out that I’m a poor metaboliser of the statin I’d been prescribed – my body couldn’t break it down properly, so it was building up and causing side effects. Thanks to the test results, my doctor was able to switch me to a different statin that suits my genetic profile. I’ve been able to manage my cholesterol without the horrible side effects I had before."
– Ms S, Cotswolds -
![]()
"After surgery, I was in a lot of pain, but the usual painkillers weren’t helping much. I took the Mantara PGx test and found out I’m a poor metaboliser of certain opioids – no wonder they weren’t working. Armed with that info, my doctor switched me to something more suitable, and the difference was huge. My recovery became much more manageable after that."
– Mr B, Oxford -
![]()
"I’d been struggling with side effects from several different antidepressants. Nothing seemed to work quite right. The Mantara test helped identify that I was metabolising some drugs too quickly – so they didn’t help – and others too slowly, which was causing side effects. With that insight, my doctor changed my medication and I finally started to feel more stable, with fewer side effects. It was a real turning point."
– Mr M, Somerset
Discover How Mantara Can Help You:
Find out more about the process of PGx testing with Mantara.
Learn about Mantara’s unique, research-backed approach.